Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

INTRODUCTION: Immunoglobulin G4-related disease (IgG4-RD) is a debilitating multiorgan disease characterized by recurring flares leading to organ dysfunction, decreased quality of life, and mortality. Glucocorticoids, the standard of care for IgG4-RD, are associated with substantial treatment-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Perugino, Cory, Culver, Emma L., Khosroshahi, Arezou, Zhang, Wen, Della-Torre, Emanuel, Okazaki, Kazuichi, Tanaka, Yoshiya, Löhr, Matthias, Schleinitz, Nicolas, Falloon, Judith, She, Dewei, Cimbora, Daniel, Stone, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654302/
https://www.ncbi.nlm.nih.gov/pubmed/37792260
http://dx.doi.org/10.1007/s40744-023-00593-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654302/
https://www.ncbi.nlm.nih.gov/pubmed/37792260
http://dx.doi.org/10.1007/s40744-023-00593-7

Ejemplares similares